erdosteine has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erdogan, H; Fadillioglu, E; Irmak, MK; Sogut, S; Ucar, M; Yagmurca, M | 1 |
| Akcay, A; Bayrak, R; Karanfil, A; Kaya, A; Ozkara, A; Sahin, S; Selcoki, Y; Uz, B; Uz, E | 1 |
2 other study(ies) available for erdosteine and Cardiac Diseases
| Article | Year |
|---|---|
Erdosteine prevents doxorubicin-induced cardiotoxicity in rats.
Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Blood Pressure; Body Weight; Creatine Kinase; Doxorubicin; Drug Administration Schedule; Heart Diseases; Heart Rate; Humans; Injections, Intraperitoneal; L-Lactate Dehydrogenase; Male; Myocardium; Organ Size; Peroxidase; Rats; Rats, Sprague-Dawley; Thioglycolates; Thiophenes; Turkey | 2003 |
The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
Topics: Animals; Catalase; Chemoprevention; Cyclosporine; Disease Models, Animal; Expectorants; Fibrosis; Glutathione Peroxidase; Heart; Heart Diseases; Immunosuppressive Agents; Male; Malondialdehyde; Myocardium; Nitric Oxide; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase; Thioglycolates; Thiophenes | 2007 |